Literature DB >> 12729656

Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.

Robert J Kerns1, Michael J Rybak, Glenn W Kaatz, Flamur Vaka, Raymond Cha, Richard G Grucz, Veena U Diwadkar, Tracey D Ward.   

Abstract

The synthesis of symmetric and asymmetric piperazinyl-linked dimers of the fluoroquinolone class of antibiotics is described. Specific dimers are shown to possess potent antibacterial activity against drug-resistant strains of Staphylococcus aureus, including strains possessing resistance due to the NorA multidrug efflux pump and a mutation in the quinolone resistance-determining region of topoisomerase IV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729656     DOI: 10.1016/s0960-894x(03)00208-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.

Authors:  Muhammad Malik; Tao Lu; Xilin Zhao; Anubha Singh; Christopher M Hattan; John Domagala; Robert Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.

Authors:  Gregory T Robertson; Eric J Bonventre; Timothy B Doyle; Qun Du; Leonard Duncan; Timothy W Morris; Eric D Roche; Dalai Yan; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

4.  Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.

Authors:  Katherine A Gould; Xiao-Su Pan; Robert J Kerns; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

5.  A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.

Authors:  Gregory T Robertson; Timothy B Doyle; Qun Du; Leonard Duncan; Khisimuzi E Mdluli; A Simon Lynch
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

6.  Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.

Authors:  Zhi Xu; Shu Zhang; Lian-Shun Feng; Xiao-Ning Li; Guo-Cheng Huang; Yun Chai; Zao-Sheng Lv; Hui-Yuan Guo; Ming-Liang Liu
Journal:  Molecules       Date:  2017-07-13       Impact factor: 4.411

7.  Brown and Red Seaweeds Serve as Potential Efflux Pump Inhibitors for Drug-Resistant Escherichia coli.

Authors:  Wen-Jung Lu; Hsuan-Ju Lin; Pang-Hung Hsu; Margaret Lai; Jen-Yu Chiu; Hong-Ting Victor Lin
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.